China’s command economy hits great wall of the free market
“They’ve gone about as fur as they c’n go.” Sixty years ago, Richard Rodgers and Oscar Hammerstein used those words to describe the state of affairs in Kansas City in the musical “Oklahoma.” But I can’t think of a better way to describe what’s going on in China. The Middle Kingdom appears to have hit Read More →
Read More →Justin’s Winery of the Year honor beyond ‘wildest dreams’
I asked Justin Baldwin what message he would deliver later this month at an awards dinner in New York honoring Justin Vineyards & Winery as Wine Enthusiast magazine’s American Winery of the Year. “Wow” was the first word that came to mind. He recalled that when he started the operation 35 years ago, it was Read More →
Read More →Forced arbitration violates your rights
By Lisa Spiwak Arbitration has become very popular as an alternative dispute resolution to the traditional court system. Arbitration’s popularity stems from the fact that it is a way to resolve legal disputes outside of the courts in a faster, cheaper and more flexible manner. Arbitration awards are completely binding on the parties and those Read More →
Read More →Internet of Things lights up CES
By David Newton LAS VEGAS — Another year at the Consumer Electronics Show and more records fell. Attendance topped 173,000 — including 50,000 from outside the U.S. — with 3,800 exhibitors covering 2.5 million square feet. But this year did not have any truly impressive, jaw-dropping product-tech debuts and felt very much like the last Read More →
Read More →Amgen suffers setback as patent office refuses to review competitor’s drug
The U.S. Patent and Trademark Office handed Amgen a potential setback Jan. 14 when it declined to review two patent expiration dates on a competitor’s drug. In June, Thousand Oaks-based biotech giant Amgen asked the agency to review two formulation patents for Humira, made by Chicago-based competitor AbbVie, arguing that the patents should not have Read More →
Read More →